The FDA announced on September 30, 2011, that VistaPharm, Inc. voluntarily recalled Xactdose Phenytoin Oral Suspension due to defective containers that may cause viscosity and assay failures. The agency issued recall number D-1440-2012 for the Class II recall.
How to tell if you have it
- Brand: VistaPharm
- Product: Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL
- Packaging: 5 mL unit dose cups
- NDC: 66689-036-50
- Lot codes: 210900, 214000, 220100, 224800, 228700, 232800
- Distribution: Nationwide
- Units affected: 27,221 unit dose cups
The hazard
The defective container lidding deformity allows the product to transpire, leading to moisture loss. This moisture loss causes the viscosity and assay levels to increase relative to the sample volume.
Context
GovInfoNow's records show VistaPharm, Inc. has had 19 other recalls on record since January 19, 2011. Other recent recalls of similar products include ANI Pharmaceuticals Estradiol Gel recall (May 12, 2026), Apotex Desmopressin Nasal Spray recall (April 8, 2026), and Sun Pharmaceutical Diclofenac Gel recall (January 27, 2026).